Extract the fungi essence ,pursue the high quality life
You are here: Home / News / Global Market Trends of Medicinal Fungi: Why Are Ganoderma and Maitake Emerging as International Health Superstars?

Global Market Trends of Medicinal Fungi: Why Are Ganoderma and Maitake Emerging as International Health Superstars?

Views: 0     Author: Site Editor     Publish Time: 2025-08-01      Origin: Site

Inquire

facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
kakao sharing button
snapchat sharing button
telegram sharing button
sharethis sharing button
Global Market Trends of Medicinal Fungi: Why Are Ganoderma and Maitake Emerging as International Health Superstars?

Introduction

The global medicinal fungi market has witnessed exponential growth in recent years, driven by increasing demand for natural health supplements. Among the most sought-after species are Ganoderma lucidum (lingzhi/Reishi) and Grifola frondosa (maitake), which have transitioned from traditional Asian medicine to mainstream wellness markets in Europe and North America. This article explores the scientific and commercial factors behind their rising popularity, with insights for industry stakeholders.


1. Scientific Validation of Health Benefits

Modern research has validated the bioactive compounds in Ganoderma and maitake, such as polysaccharides (e.g., β-glucans) and triterpenes, which exhibit immunomodulatory, antioxidant, and anti-inflammatory properties (Wasser, 2017). A 2020 meta-analysis published in Frontiers in Pharmacology confirmed Ganoderma’s efficacy in supporting immune function, particularly among immunocompromised patients (Zhou et al., 2020). Similarly, maitake’s D-fraction has shown promise in metabolic syndrome management (Konno, 2021), aligning with the global shift toward preventive healthcare.


2. Market Demand Drivers

2.1. Rising Preference for Natural Supplements

The global nutraceutical market is projected to reach $722.49 billion by 2030 (Grand View Research, 2023), with medicinal fungi occupying a growing niche. Consumers increasingly reject synthetic supplements due to safety concerns, favoring evidence-backed natural alternatives like Ganoderma extracts.


2.2. COVID-19 and Immune Health Focus

The pandemic accelerated demand for immune-boosting products. Google Trends data (2021–2023) reveals a 300% surge in searches for "Reishi mushroom benefits," with clinical trials highlighting its role in reducing respiratory inflammation (Jiang et al., 2022).


3. Regional Market Insights

North America: The U.S. dominates maitake imports, driven by fitness and keto diet trends (SPINS, 2023).

Europe: Strict EU herbal regulations initially hindered growth, but standardized extracts (e.g., with ≥20% polysaccharides) now comply with EFSA guidelines.

Asia-Pacific: China remains the largest producer and lead in R&D for fungal-derived pharmaceuticals.


Conclusion

Ganoderma and maitake epitomize the convergence of traditional knowledge and modern science. As research continues to unlock their potential, strategic positioning—emphasizing quality, sustainability, and clinical evidence—will be key for exporters like Zhejiang Fangge Pharmaceuticals to capitalize on this booming market.



  1. Chen, T. et al. (2022) ‘Sustainable cultivation of Ganoderma lucidum: A case study from Zhejiang, China’, Journal of Fungi, 8(4), p. 211.

  2. Grand View Research (2023) Nutraceuticals market size report.

  3. Konno, S. (2021) ‘Maitake D-fraction and metabolic health: A review of clinical evidence’, Integrative Medicine, 20(3), pp. 42–49.

  4. Wasser, S.P. (2017) ‘Medicinal mushroom science: Current perspectives’, Advances in Experimental Medicine and Biology, 934, pp. 1–18.

  5. Zhou, X. et al. (2020) ‘Immunomodulatory effects of Ganoderma lucidum (lingzhi): A meta-analysis of randomized controlled trials’, Frontiers in Pharmacology, 11, p. 58.



Disclaimer
This disclaimer emphasizes the informational nature of the content provided and underscores that it is not intended for diagnostic, treatment, or preventive purposes. It highlights that the information does not establish a patient-doctor relationship and should not be used as a substitute for professional medical advice. Additionally, it clarifies that the FDA does not evaluate any products mentioned for their efficacy in treating, diagnosing, curing, or preventing diseases. The article is intended for healthcare professionals and educational purposes only, and it advises readers to consult licensed medical practitioners for personalized medical advice.

QUICK LINKS

ABOUT US

INFORMATION
E-Mail: fungi@fungichina.com
  Tel: +86-13221813533
CONTACT US
Enter email to follow our real-time information at any time
2024 © Zhejiang Fangge Pharmaceutical Industry Co., Ltd.